Waclawiczek H W, Pimpl W
Chirurg. 1986 May;57(5):330-1.
The fibrin sealing was employed in connection with lymph node dissections - on one hand intraoperatively in order to avoid lymph fistulae (n = 26), on the other hand postoperatively in treatment of manifest lymph fistulae (n = 9). Thereby lymph fistulae could be avoided in 96.2% (n = 25) resp. a quick successful treatment of the lymph fistulae could be achieved in 7 of 9 cases (77%). On the average a quantity of 1 ml of fibrin sealant was sufficient; a high concentration of aprotinin (3500 IU) and thrombin (500 IU) was chosen. No side effects on part of the fibrin sealing were noted.
纤维蛋白封闭剂用于淋巴结清扫术中及术后，一方面术中使用以避免淋巴瘘（n = 26），另一方面术后用于治疗明显的淋巴瘘（n = 9）。由此，分别有96.2%（n = 25）的患者避免了淋巴瘘，9例患者中有7例（77%）淋巴瘘得到快速成功治疗。平均1毫升纤维蛋白封闭剂就足够；选择了高浓度的抑肽酶（3500 IU）和凝血酶（500 IU）。未观察到纤维蛋白封闭剂有任何副作用。
